Total Payments
$131,943
2024 Payments
$1,268
Companies
45
Transactions
241
Medicare Patients
49,145
Medicare Billing
$9.4M
Payment Breakdown by Category
Research$106,763 (80.9%)
Gifts$9,314 (7.1%)
Travel$8,590 (6.5%)
Food & Beverage$6,185 (4.7%)
Consulting$1,000 (0.8%)
Education$90.80 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $106,763 | 8 | 80.9% |
| Gift | $9,314 | 11 | 7.1% |
| Travel and Lodging | $8,590 | 24 | 6.5% |
| Food and Beverage | $6,185 | 194 | 4.7% |
| Consulting Fee | $1,000 | 1 | 0.8% |
| Education | $90.80 | 3 | 0.1% |
Payments by Type
Research
$106,763
8 transactions
General
$25,180
233 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca UK Limited | $76,913 | 4 | $0 (2018) |
| Philips Electronics North America Corporation | $21,510 | 5 | $0 (2020) |
| Abbott Laboratories | $10,427 | 6 | $0 (2022) |
| Bard Peripheral Vascular, Inc. | $9,314 | 11 | $0 (2018) |
| Medtronic Vascular, Inc. | $4,414 | 35 | $0 (2020) |
| Penumbra, Inc. | $2,730 | 8 | $0 (2019) |
| Surmodics, Inc. | $1,480 | 4 | $0 (2018) |
| Janssen Research & Development, LLC | $1,134 | 8 | $0 (2024) |
| Amgen Inc. | $542.89 | 18 | $0 (2023) |
| CryoLife, Inc. | $504.80 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,268 | 13 | Janssen Research & Development, LLC ($1,134) |
| 2023 | $429.66 | 10 | Mentor Worldwide LLC ($235.13) |
| 2022 | $1,572 | 22 | Abbott Laboratories ($1,000) |
| 2021 | $354.43 | 15 | AstraZeneca Pharmaceuticals LP ($75.00) |
| 2020 | $23,430 | 28 | Philips Electronics North America Corporation ($20,500) |
| 2019 | $12,705 | 47 | Abbott Laboratories ($9,361) |
| 2018 | $17,882 | 54 | Bard Peripheral Vascular, Inc. ($9,314) |
| 2017 | $74,303 | 52 | AstraZeneca UK Limited ($71,480) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Cardio-renal | ||||||
| 08/23/2024 | Mentor Worldwide LLC | MENTOR MemoryGel Resterilizable Gel Sizer (Device) | Food and Beverage | In-kind items and services | $60.89 | General |
| Category: Plastic Surgery | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: VACCINE | ||||||
| 07/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/08/2024 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $289.73 | General |
| 03/08/2024 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 03/08/2024 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $124.86 | General |
| 03/08/2024 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 03/08/2024 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 03/08/2024 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 03/08/2024 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 02/15/2024 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $429.84 | General |
| 09/11/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: RESPIRATORY | ||||||
| 08/25/2023 | Mentor Worldwide LLC | MENTOR MemoryShape Breast Implant (Device) | Food and Beverage | In-kind items and services | $90.21 | General |
| Category: Plastic Surgery | ||||||
| 08/23/2023 | Mentor Worldwide LLC | MENTOR MemoryShape Breast Implant (Device) | Food and Beverage | In-kind items and services | $144.92 | General |
| Category: Plastic Surgery | ||||||
| 08/08/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $28.23 | General |
| Category: Cardiovascular | ||||||
| 06/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/10/2023 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/11/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Cardiology | ||||||
| 03/15/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: VACCINES | ||||||
| 03/07/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $27.21 | General |
| Category: Cardiovascular | ||||||
| 01/30/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia | AstraZeneca UK Limited | $76,913 | 4 |
| ILLUMENATE | Philips Electronics North America Corporation | $12,500 | 2 |
| XIENCE SHORT DAPT 28 US | Abbott Laboratories | $9,350 | 1 |
| Tack Optimized Balloon Angioplasty Study of the Tack Endovascular in Femoropoliteal Arteries (TOBA II) | Philips Electronics North America Corporation | $8,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 64 | 12,235 | 33,280 | $6.8M | $2.1M |
| 2022 | 66 | 12,383 | 35,594 | $7.2M | $2.2M |
| 2021 | 69 | 12,753 | 39,557 | $8.1M | $2.8M |
| 2020 | 67 | 11,774 | 34,544 | $6.6M | $2.2M |
Total Patients
49,145
Total Services
142,975
Medicare Billing
$9.4M
Procedure Codes
278
All Medicare Procedures & Services
278 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,033 | 4,287 | $971,475 | $461,872 | 47.5% |
| 37227 | Removal of plaque and insertion of stents in arteries of leg | Office | 2023 | 27 | 32 | $1.9M | $371,308 | 19.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 313 | 320 | $240,000 | $147,001 | 61.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 640 | 665 | $399,000 | $124,083 | 31.1% |
| 36247 | Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | Office | 2023 | 59 | 88 | $521,840 | $92,344 | 17.7% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 51 | 82 | $287,000 | $90,136 | 31.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 239 | 1,017 | $152,550 | $70,473 | 46.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 78 | 722 | $97,470 | $69,852 | 71.7% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 69 | 69 | $110,400 | $62,484 | 56.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 293 | 307 | $130,475 | $59,223 | 45.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 189 | 215 | $80,625 | $51,584 | 64.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 589 | 733 | $128,275 | $40,845 | 31.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 208 | 249 | $80,925 | $38,132 | 47.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 134 | 135 | $94,500 | $30,822 | 32.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 137 | 143 | $61,490 | $26,513 | 43.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 154 | 154 | $38,500 | $23,551 | 61.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 530 | 770 | $45,730 | $22,338 | 48.8% |
| 77075 | Complete x-ray of body bones | Office | 2023 | 179 | 182 | $54,600 | $17,984 | 32.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 92 | 92 | $36,800 | $17,785 | 48.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 420 | 433 | $91,796 | $17,007 | 18.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 90 | 156 | $31,200 | $16,453 | 52.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 130 | 130 | $39,000 | $16,322 | 41.9% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 224 | 240 | $90,000 | $15,709 | 17.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 593 | 946 | $38,980 | $15,571 | 39.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 650 | 1,164 | $34,920 | $15,272 | 43.7% |
About Dr. Ashit Jain, M.D
Dr. Ashit Jain, M.D is a Internal Medicine healthcare provider based in Fremont, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154344919.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashit Jain, M.D has received a total of $131,943 in payments from pharmaceutical and medical device companies, with $1,268 received in 2024. These payments were reported across 241 transactions from 45 companies. The most common payment nature is "" ($106,763).
As a Medicare-enrolled provider, Jain has provided services to 49,145 Medicare beneficiaries, totaling 142,975 services with total Medicare billing of $9.4M. Data is available for 4 years (2020–2023), covering 278 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Fremont, CA
- Active Since 07/25/2006
- Last Updated 04/22/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1154344919
Products in Payments
- EPANOVA (Drug) $76,913
- Stellarex (Device) $13,488
- Xience (Device) $9,350
- IGT Devices Und (Device) $8,000
- FLUENCY (Device) $3,967
- Resolute (Device) $3,700
- Indigo (Device) $2,730
- SurVeil (Device) $1,480
- DECATHLON (Device) $1,380
- VACCESS (Device) $1,080
- OMNILINK ELITE (Device) $1,000
- ULTRAVERSE (Device) $878.00
- GLIDEPATH (Device) $802.00
- ATLAS (Device) $695.00
- DORADO (Device) $512.00
- On-X (Device) $504.80
- TurboHawk (Device) $492.71
- Repatha (Biological) $399.26
- ELIQUIS (Drug) $363.20
- LifeVest (Device) $281.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fremont
Dr. Varun Chawla
Internal Medicine — Payments: $75,053
Internal Medicine $75,053
Dr. Charles Valone, D.o, D.O
Internal Medicine — Payments: $55,834
Internal Medicine $55,834
Dr. Michael Lenoir, Md, MD
Internal Medicine — Payments: $51,051
Internal Medicine $51,051
Robert Su, M.d, M.D
Internal Medicine — Payments: $37,209
Internal Medicine $37,209
Daniel Taylor, M.d, M.D
Internal Medicine — Payments: $20,686
Internal Medicine $20,686
Rajiv Ahuja, M.d, M.D
Internal Medicine — Payments: $15,535
Internal Medicine $15,535